Skip to content

Rocket Pharmaceuticals, Inc.: filings

Every Rocket Pharmaceuticals, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 46 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-10fiscal Q2 2026421240001193125-26-342348
10-Q2026-05-07fiscal Q1 202640840001193125-26-211873
10-K2026-02-26fiscal FY 202543870001193125-26-076551
10-Q2025-11-06fiscal Q3 2025401200001193125-25-269474
10-Q2025-08-07fiscal Q2 2025401160000950170-25-104996
10-Q2025-05-08fiscal Q1 202540840000950170-25-066898
10-K2025-02-27fiscal FY 2024401050000950170-25-029002
10-Q2024-11-07fiscal Q3 2024401200000950170-24-123459
10-Q2024-08-06fiscal Q2 2024411180000950170-24-091838
10-Q2024-05-07fiscal Q1 202441860000950170-24-054465
10-K2024-02-27fiscal FY 2023421100000950170-24-021096
10-Q2023-11-07fiscal Q3 2023401160000950170-23-060339
10-Q2023-08-09fiscal Q2 2023401130001140361-23-038855
10-Q2023-05-05fiscal Q1 202340820001140361-23-023233
10-K2023-02-28fiscal FY 2022421070001140361-23-009252
10-Q2022-11-04fiscal Q3 2022401160001140361-22-040004
10-Q2022-08-09fiscal Q2 2022401120001140361-22-028904
10-Q2022-05-06fiscal Q1 202240820001140361-22-018101
10-K2022-02-28fiscal FY 2021421080001140361-22-007036
10-Q2021-11-05fiscal Q3 2021421220001140361-21-036826
10-Q2021-08-09fiscal Q2 2021421180001140361-21-027561
10-Q2021-05-10fiscal Q1 202141840001140361-21-016643
10-K2021-03-01fiscal FY 2020391310001140361-21-006677
10-Q2020-11-06fiscal Q3 2020371020001140361-20-024856
10-Q2020-08-05fiscal Q2 2020381000001140361-20-017582
10-Q2020-05-08fiscal Q1 202036740001140361-20-011097
10-K2020-03-06fiscal FY 201939780001140361-20-005056
10-Q2019-11-08fiscal Q3 2019371020001140361-19-020183
10-Q2019-08-08fiscal Q2 201937980001140361-19-014585
10-Q2019-05-09fiscal Q1 201936740001140361-19-008828
10-K2019-03-08fiscal FY 2018351260001140361-19-004603
10-Q2018-11-09fiscal Q3 201834910001140361-18-042845
10-Q2018-08-14fiscal Q2 201835930001140361-18-036347
10-Q2018-05-11fiscal Q1 201834710001140361-18-023041
10-K2018-03-07fiscal FY 201727550001564590-18-004621
10-Q2017-11-08fiscal Q3 201726680001564590-17-022495
10-Q2017-08-03fiscal Q2 201726660001564590-17-015386
10-Q2017-05-10fiscal Q1 201726530001564590-17-010064
10-K2017-03-16fiscal FY 201626540001564590-17-004532
10-Q2016-11-09fiscal Q3 201626680001564590-16-028485
10-Q2016-08-10fiscal Q2 201626660001193125-16-677550
10-Q2016-05-11fiscal Q1 201626520001193125-16-586428
10-K2016-03-23fiscal FY 201527530001193125-16-514228
10-Q2015-11-12fiscal Q3 201526660001193125-15-374713
10-Q2015-08-07fiscal Q2 201526640001193125-15-281532
10-Q2015-05-14fiscal Q1 201521430001193125-15-188339

Inspect the source

Entity
Rocket Pharmaceuticals, Inc. / CIK 0001281895
Captured
2026-09-20T07:48:45.204Z
SEC response SHA-256
0bcbe84a05b7de7c12edb430923484b522633d995abac19aad70bdfd9e60b3ef

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001281895.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))